Patients with STGD1 commonly present with progressive bilateral central vision loss ... loss was 1.6-fold greater than the area of RPE atrophy, which suggests that photoreceptor degeneration may ...

AI-powered research on one of the largest eye studies to date has created the most detailed maps of the retina ever produced.

In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...

Australia has become the first country outside of the United States to approve the use of the drug pegcetacoplan (SYFOVRE) to slow down the progression of geographic atrophy.

Panelists discuss how both medications demonstrate favorable safety profiles in clinical trials, with aflibercept 8 mg benefiting from extensive 2-mg safety data, while acknowledging the need to ...

Panelists discuss how faricimab’s dual inhibition of Ang-2 provides additional benefits in vascular stability and inflammation reduction beyond VEGF-A suppression alone, potentially leading to ...